Australia is gain access to a groundbreaking therapy for obesity: Retatrutide. This dual compound – acting on both GLP-1 and GIP receptors – shows remarkable results in international trials, pointing to considerable reductions in body fat. While regulatory clearance is pending with Australian regulators, several Australians dealing with being o